Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
HPV vaccination trends from 2016 to 2025: Progress and missed opportunities
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
Disrupting Healthcare Audiences: A new standard for precision and accuracy
"Healthcare audience targeting has changed fast, and expectations have climbed even faster." As...
.png)
Building guardrails for AI-driven real-world data programs
AI is rapidly reshaping how real-world data (RWD) is generated and analyzed across healthcare...
5 questions RWE & HEOR teams should ask data vendors in an RFP
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal...
Primary biliary cholangitis: Disease burden, treatments and RWD gaps
Understanding PBC and today’s treatment landscape Primary biliary cholangitis (PBC) is a chronic...
Insights in healthcare marketing start with truth, not inference
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...
Measuring psoriasis severity, outcomes and comorbidities using real-world data
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic...
How GLP-1 direct-to-consumer programs are distorting utilization trends
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...